Its October check of 21 US telehealth programs found compounded semaglutide at a $175 median, with a $79 sale low, counting memberships in the all-in price.
Recap by typeshit. Full story at BioSpace.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
The pact adds to a busy run of China deals for Roche and is a bet on medicines that lower visceral fat.
He says the peptide has almost no human data and is only sold online as a research chemical, so both the compound and its sourcing carry unknown risks.
Loading…